About this episode
Most people think heart disease is something that happens suddenly. A blocked artery. A heart attack. An emergency that seems to come out of nowhere. But what if that entire framing is wrong? What if cardiovascular disease isn't an event, but a decades-long metabolic process quietly unfolding beneath the surface? Plaque building slowly, Insulin rising gradually, inflammation simmering in the background, and hormonal protection shifting over time. All while your labs look "normal," you feel "fine," and no one is sounding the alarm. That's the gap. Our healthcare system is exceptional at saving lives in crisis, but it was built to respond to heart attacks, not to ask what was happening 10, 20, or even 30 years before that event. And labs are where most people get falsely reassured. A standard lipid panel might look acceptable, your glucose might fall within range, and your doctor might tell you everything is stable. But stable doesn't necessarily mean low risk. LDL alone doesn't tell the full story, normal glucose doesn't rule out insulin resistance, and inflammation can be actively contributing to vascular damage long before symptoms ever show up. In this episode, interventional cardiologist Dr. Sanjay Bhojraj and I pull back the curtain on what most people miss when it comes to cardiovascular screening. We explore the hidden metabolic dysfunction that drives plaque progression, the advanced labs that reveal risk earlier, and how to think differently about prevention if your goal isn't just surviving a heart attack… but never having one in the first place. Things You'll Learn In This Episode Heart disease is a process, not a sudden event If plaque progression begins early and builds silently, what markers reveal that process long before a crisis ever happens? "Normal" labs can hide real cardiovascular risk When cholesterol, glucose, and blood pressure fall within range, what underlying dysfunction might still be developing beneath the surface? LDL isn't the full story If ApoB reflects the number of atherogenic particles driving plaque formation, why does it often tell a different story than a standard lipid panel? Hormones and inflammation reshape cardiovascular protection How do shifts in estrogen, chronic inflammation, and metabolic stress alter plaque progression, and what does that mean for long-term prevention? Guest Bio Dr. Sanjay Bhojraj is a board-certified cardiologist and interventional cardiologist who spent more than two decades in the cath lab treating heart attacks and complex coronary disease. After years on the front lines of acute cardiac care, he experienced a pivotal shift in perspective, recognizing that while conventional medicine is except
